medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2013, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2013; 11 (4)

Scleromyxedema: Case Report

Barragán EZF, Guevara CRM, López IMM, Quintal RMJ

Language: Spanish
References: 16
Page: 253-256
PDF size: 163.38 Kb.


ABSTRACT

Scleromyxedema is a cutaneous mucinosis featuring generalized papular eruption, mucin deposits, fibroblast proliferation, fibrosis and monoclonal gammopathy without concurrent thyroid disease. Gottron introduced the term scleromyxedema in 1954 to describe the sclerotic variant of papular mucinosis. Several authors have described patients presenting lichenoid papules and scleroderma-like lesions. This is the case report of a 69 year-old diabetic female with this rare entity.


REFERENCES

  1. Bata-Csorgo Z, Husz S, Foldes M, Korom J, Molnar K, Morvay M, et al. “Scleromyxedema”. J Am Acad Dermatol 1999; 40: 343-346.

  2. Gómez-Díez S, Maldonado C, López-Escobar M, Manjón JA, Jalón A, Rodríguez-Vigil T, Pérez-Oliva N. “Escleromixedema”. Actas Dermosifiliogr 2003; 94(9): 627-630.

  3. Godby A, Bergstresser P, Chaker B, Pandya A. “Fatal scleromyxedema: Report of a case and review of the literature”. J Am Acad Dermatol 1998; 38: 289-294.

  4. Daoud M, Lust John, Kyle R, Pittelkow M. “Monoclonal gammopathies and associated skin disorders”. J Am Acad Dermatol 1999; 40(4): 507-535.

  5. Rongioletti F, Rebora A. “Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema”. J Am Acad Dermatol 2001; 44: 273-281.

  6. Stetsenko G, Vary J , Olerud J, Argenyi Z. “Unusual granulomatous variant of scleromyxedema”. J Am Acad Dermatol 2008; 59: 346-349.

  7. Rey J, Luria R. “Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin”. J Am Acad Dermatol 2009; 60: 1037-1041.

  8. Godby A., Bergstresser P. , Chaker B., Pandya M. “Fatal scleromyxedema: Report of a case and review of the literature”. J Am Acad Dermato 1998; 38: 289-294.

  9. Yaron M, Yaron I, Brenner S. ”Lichen myxedematosus (Scleromyxedema) serum stimulates hyaluronic acid and prostaglandin production by human fibroblasts”. Rheumatol 1985; 12: 171-175.

  10. Horn K, Horn M, Swan J, Singhal S, Guitart J. “A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema”. J Am Acad Dermatol 2004; 51: S120-123.

  11. Heymman W. “Scleromyxedema”. J Am Acad Dermatol 2007; 57: 890-891.

  12. Iranzo P, Lopez-Lerma I, Blade J, Rovira M, Herrero C. “Scleromyxoedema treated with autologous stem cell transplantation”. J Eur Acad Dermatol Venereol 2007; 21: 129-130.

  13. Lacy MQ, Hogan WJ, Gertz MA, Dispenzieri A, Rajkumar SV, Hayman S, et al. “Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation”. Arch Dermatol 2005; 141: 1277-1282.

  14. Dinneen AM, Dicken CH. “Scleromyxedema”. J Am Acad Dermatol 1995; 33: 37-43.

  15. Blum M, Wigley FM, Hummers LK. “Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG)”. Medicine 2008; 87: 10-20.

  16. Brunet-Possenti F, Hermine O, Marinho E, Crickx B, Descamps V. “Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema”. J Am Acad Dermatol 2013; 69(2): 319-320.




2020     |     www.medigraphic.com